Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy GoodRx stock (GoodRx)

Buy GoodRx stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

GoodRx is now publicly available to trade. The stock opened at $46, nearly 40% above it's IPO price of $33.

Launched in 2011, GoodRx allows customers to compare prescription drug prices. It's since become a household name, which may be one of the reasons that the stock has been getting so much buzz. If you're planning to invest, here's how you can buy in.

Our top picks for where to buy Goodrx Holdings Inc stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy GoodRx stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GDRX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy GoodRx stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

GoodRx stock price (NASDAQ: GDRX)

Use our graph to track the performance of GDRX stocks over time.

GoodRx shares at a glance

Information last updated 2024-12-19.
Latest market close$4.49
52-week range$4.09 - $9.26
50-day moving average $5.52
200-day moving average $7.04
Wall St. target price$7.15
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.04

Is it a good time to buy GoodRx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

GoodRx price performance over time

Historical closes compared with the close of $4.37 from 2024-12-18

1 week (2024-12-13) -7.22%
1 month (2024-11-21) 1.86%
3 months (2024-09-20) -36.76%
6 months (2024-06-20) -43.97%
1 year (2023-12-20) -30.52%
2 years (2022-12-20) -6.22%
3 years (2021-12-20) 33.69
5 years (2019-12-17) N/A

Is GoodRx stock undervalued or overvalued?

Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

GoodRx's EBITDA

GoodRx's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $106.6 million.

The EBITDA is a measure of a GoodRx's overall financial performance and is widely used to measure a its profitability.

To put GoodRx's EBITDA into context you can compare it against that of similar companies.

GoodRx financials

Revenue TTM $790.4 million
Operating margin TTM 10.48%
Gross profit TTM $701.5 million
Return on assets TTM 4.21%
Return on equity TTM -2.06%
Profit margin -2.05%
Book value $1.83
Market Capitalization $1.7 billion

TTM: trailing 12 months

GoodRx share dividends

We're not expecting GoodRx to pay a dividend over the next 12 months.

You may also wish to consider:

GoodRx share price volatility

Over the last 12 months, GoodRx's shares have ranged in value from as little as $4.09 up to $9.2599. A popular way to gauge a stock's volatility is its "beta".

GDRX.US volatility(beta: 1.39)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GoodRx's is 1.393. This would suggest that GoodRx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put GoodRx's beta into context you can compare it against those of similar companies.

GoodRx overview

GoodRx Holdings, Inc. , together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. .

Frequently asked questions

What percentage of GoodRx is owned by insiders or institutions?
Currently 12% of GoodRx shares are held by insiders and 70.738% by institutions.
How many people work for GoodRx?
Latest data suggests 694 work at GoodRx.
When does the fiscal year end for GoodRx?
GoodRx's fiscal year ends in December.
Where is GoodRx based?
GoodRx's address is: 2701 Olympic Boulevard, Santa Monica, CA, United States, 90404
What is GoodRx's ISIN number?
GoodRx's international securities identification number is: US38246G1085

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site